More intelligence articles

The Cystic Fibrosis Buyers’ Club

Patients versus Pharma: campaigners using direct action to fight for access

Innovation and digital health comms recognised at Communiqué Awards

Two of this year's most groundbreaking campaigns

Building Europe’s next breakthrough biotechs

Start Codon's Daniel Rooke on fostering biotech success in Cambridge, UK

For trials without tribulations, we must improve patient experience

Clinical trials are broken and only patients can help us fix them - if we let them

Breaking from tradition - social media at medical congresses

How social media can improve HCPs' experience

Streamlining clinical trials – why better data use is key

A new EU in the making, what lies ahead for pharma?

Big decisions on Europe's leaders and strategy await

What pharma marketers can learn from Disney

Why we need to continue to innovate, and surprise our audience

Biotech profile: Tom Evans, CEO, Vaccitech.

Can UK-based company be first to develop a universal flu vaccine?

The social dilemma: is it time for pharma to join the party?

Chris Ross explores why social media still isn’t trending for pharma, and how it can join in the fun

25 Women Leaders in UK Healthcare

Women trailblazers helping to shape the future of healthcare (Part 1)

25 Women Leaders in UK Healthcare (part 2)

Women Leaders in UK Healthcare: Liz Henderson

Merck UK & Ireland’s MD on her ‘non-linear’ career and the importance of mentoring

It’s not the end of the world, is it?

Industry change isn’t always gradual – it can be apocalyptic

Is anybody listening?

Chris Ross explores how pharma can – indeed must – end its long history of anti-social behaviour